Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation

Chronic Obstructive Pulmonary Disease-V: Management

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.

COPD: Pathogenesis and Clinical Features

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:

Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

International Society for Heart and Lung Transplantation Scientific Statement on pulmonary antibody-mediated rejection and proposed graft, antibody, and pathology (GAP) definition.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026

Same author

Allergic Diseases During Pregnancy: Reassuring Uncertainty.

The journal of allergy and clinical immunology. In practice·2026

Same author

Shared Decision-Making and Health-Related Quality of Life in Drug Allergy.

The journal of allergy and clinical immunology. In practice·2026

Same author

Comparative Effectiveness of Single Versus Bilateral Lung Transplantation in Dually Listed Recipients: A National Target Trial.

Annals of surgery·2026

Same author

Mosaic pathogenic <i>PRKAG2</i> variant and pathologic diagnosis of glycogen storage disease in an infant with negative whole-genome sequencing.

JHLT open·2026

Same author

Archetype analysis of lung adenocarcinoma premalignancy links heterogeneity in premalignant lesions to diverging features of invasive disease.

Molecular cancer research : MCR·2026

Search research articles

Related Experiment Video

Updated: Nov 4, 2025

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation

Published on: November 10, 2023

Chronic Lung Allograft Dysfunction: Evolving Concepts and Therapies.

Olawale Amubieya¹, Allison Ramsey¹, Ariss DerHovanessian¹

¹Division of Pulmonary, Critical Care Medicine, Allergy, and Clinical Immunology, Department of Internal Medicine, The David Geffen School of Medicine at UCLA, Los Angeles, California.

Seminars in Respiratory and Critical Care Medicine

|May 24, 2021

Summary

Chronic lung allograft dysfunction (CLAD) is a major barrier to long-term lung transplant survival. This review covers updated CLAD definitions, phenotypes, and emerging strategies for prevention and treatment.

More Related Videos

Implantation of Fibrin Gel on Mouse Lung to Study Lung-specific Angiogenesis

Implantation of Fibrin Gel on Mouse Lung to Study Lung-specific Angiogenesis

Published on: December 21, 2014

Orthotopic Left Lung Transplantation in Rats

Orthotopic Left Lung Transplantation in Rats

Published on: July 3, 2025

Related Experiment Videos

Last Updated: Nov 4, 2025

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation

Published on: November 10, 2023

Implantation of Fibrin Gel on Mouse Lung to Study Lung-specific Angiogenesis

Implantation of Fibrin Gel on Mouse Lung to Study Lung-specific Angiogenesis

Published on: December 21, 2014

Orthotopic Left Lung Transplantation in Rats

Orthotopic Left Lung Transplantation in Rats

Published on: July 3, 2025

Area of Science:

Pulmonology and Transplant Medicine
Immunology
Regenerative Medicine

Background:

Chronic lung allograft dysfunction (CLAD) significantly limits long-term survival and quality of life after lung transplantation.
Current understanding and management of CLAD are evolving, with recent updates to consensus definitions and phenotypes.
Existing therapies for CLAD are often ineffective, highlighting the need for novel approaches.

Purpose of the Study:

To provide an overview of recent updates in CLAD terminology, clinical phenotypes, and diagnosis.
To discuss the natural history and pathogenesis of CLAD, including potential differences among phenotypes.
To explore novel therapeutic strategies for the prevention and treatment of CLAD, including precision medicine.

Main Methods:

Review of updated consensus definitions and classifications of CLAD and its phenotypes.
Analysis of current literature on CLAD pathogenesis, risk factors, and natural history.
Synthesis of emerging research on novel preventative and therapeutic interventions for CLAD.

Main Results:

Updated CLAD definitions and phenotypes have been clarified, but their clinical impact requires further evaluation.
Understanding distinct CLAD phenotypes may pave the way for targeted, precision medicine therapies.
Identification of CLAD risk factors could enable earlier interventions to prevent its development.

Conclusions:

Novel therapeutic strategies for CLAD prevention and treatment are under investigation.
Further research into CLAD pathogenesis and risk factors is crucial for improving patient outcomes.
The evolving understanding of CLAD offers hope for more effective management and improved long-term survival post-transplant.